[Good blood pressure control even in overweight patients].
Sharma
A M
AM
Department of Medicine, Michael de Groote School of Medicine, McMaster University, Hamilton General Hospital 237 Barton Street East Hamilton, Ontario L8L 2X2, Canada. sharma@ccc.mcmaster.ca
Bramlage
P
P
Kirch
W
W
D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D000077405:Irbesartan; D008875:Middle Aged; D009765:Obesity / Q000150:complications*; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D000077405:Irbesartan